Several vaccines for adolescents and adults are recommended for inclusion in bet365 bonus code 2018’s Universal Immunisation Programme (UIP), but not much traction has happened
The Covid-19 pandemic has changed humankind in far-reaching ways—from the way we shop to the way we work to the way we unwind. Maybe even the way we approach disease prevention. For the adolescent population, if the response to bet365 bonus code 2018’s mass immunisation programme is anything to go by, getting a jab has become part of their ‘to do’ list.
bet365 bonus code 2018 has perhaps never rolled out as massive a vaccination programme for its adolescent population as it has during the Covid-19 pandemic. As of April 21, more than 25.3 million adolescents had received their first shot of the Covid-19 vaccine, according to data from the Union health ministry. This, perhaps, sets the stage for a dedicated inoculation programme for adolescents for vaccine-preventable diseases or VPDs; it is also a signal to the pharma industry to invest in this space, considering the high uptake of Covid-19 vaccines. But more on that later.
The vaccine story for adolescents in bet365 bonus code 2018 has largely been unimpressive, though there were more than 250 million adolescents (those between the ages of 10 and 19) in the country in 2021, according to UNICEF. And while bet365 bonus code 2018’s Universal Immunisation Programme (UIP) is one of the largest in the world in terms of the quantity of vaccines used and the number of beneficiaries, it is largely targeted at infants and children under five years of age. In fact, the pharma industry’s vaccine segment that caters to the adolescent and adult population witnessed de-growth of about 17 per cent in the past one year, according to AWACS, a pharma market research company.
Data shows that GSK Pharma, a segment leader, recorded de-growth of 51 per cent for its pneumonia vaccine for the March 2021-February 2022 period. Likewise, Sanofi bet365 bonus code 2018’s sales for its tetanus combination vaccines fell 25 per cent, and 44 per cent for its influenza vaccine, while Biological E. recorded a fall of 8 per cent for its tetanus vaccine. Then, Bharat Biotech witnessed over 44 per cent de-growth for its anti-rabies vaccine in the same period. Similarly, Zydus Cadila, which makes Covid-19 vaccines for adolescents, saw de-growth of 49 per cent for its influenza vaccine; and bet365 bonus code 2018n Immunologicals had de-growth of 22 per cent for its anti-rabies vaccine, AWACS data shows.
bet365 bonus code 2018 also witnessed the biggest drop in routine childhood immunisation coverage in recent times, according to data collated by the World Health Organization (WHO) and UNICEF in 2020. If bet365 bonus code 2018’s flagship routine immunisation programme, Mission Indradhanush, was dealt a massive blow, the direct impact on adolescent and adult vaccination uptake was obvious. “If one looks at the type of vaccines that have de-grown significantly, a majority of them fall in the adult vaccines category,” says Sheetal Sapale, President-Marketing, AWACS, adding that Covid-19 may be a possible reason for the dip in adult inoculations. As for the fall in children’s vaccinations, she says it could be because many couples postponed having children during the pandemic (most such vaccines are given within the first year of birth).
Several vaccines for adolescents and adults are recommended for inclusion in bet365 bonus code 2018’s Universal Immunisation Programme (UIP), but not much traction has happened 
